Epidemiologic studies have shown that cutaneous T-cell lymphoma (CTCL) patients have an increased risk of the development of a second neoplasm (SN). The aim of our study was to evaluate the risk of SN and to correlate any possible change in CTCL course after the diagnosis of a subsequent neoplasm.
Pileri, A., Guglielmo, A., Fuligni, F., Lastrucci, I., Patrizi, A., Pimpinelli, N. (2019). Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis?. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 156, 484-488 [10.23736/S0392-0488.19.06510-6].
Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis?
Pileri, Alessandro
;Guglielmo, Alba;Fuligni, Fabio;Patrizi, Annalisa;
2019
Abstract
Epidemiologic studies have shown that cutaneous T-cell lymphoma (CTCL) patients have an increased risk of the development of a second neoplasm (SN). The aim of our study was to evaluate the risk of SN and to correlate any possible change in CTCL course after the diagnosis of a subsequent neoplasm.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
